Oral testosterone ester formulations and methods of treating testosterone deficiency… Grant US-11426416-B2 United States of America 30 Aug 2022
High-strength testosterone undecanoate compositions Grant US-11364250-B2 United States of America 21 Jun 2022
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same Grant US-11331325-B2 United States of America 17 May 2022
High-strength testosterone undecanoate compositions Grant US-11311555-B2 United States of America 26 Apr 2022
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same Grant US-11179402-B2 United States of America 23 Nov 2021
Oral testosterone ester formulations and methods of treating testosterone deficiency… Grant US-11179403-B2 United States of America 23 Nov 2021
High-strength testosterone undecanoate compositions Grant US-10881671-B2 United States of America 05 Jan 2021
High-strength testosterone undecanoate compositions Grant US-10716794-B2 United States of America 21 Jul 2020
Oral testosterone ester formulations and methods of treating testosterone deficiency… Grant US-10617696-B2 United States of America 14 Apr 2020
Oral testosterone ester formulations and methods of treating testosterone deficiency… Grant US-10543219-B2 United States of America 28 Jan 2020
Oral pharmaceutical products and methods of use combining testosterone esters with… Grant US-10245273-B2 United States of America 02 Apr 2019
High-strength testosterone undecanoate compositions Grant US-10226473-B2 United States of America 12 Mar 2019
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters Grant US-9757389-B2 United States of America 12 Sep 2017
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters Grant US-9498485-B2 United States of America 22 Nov 2016